LCN2 and Alzheimer disease: Studies have shown that lipocalins have roles in cancer development [33,34,35] and a study published by Mesquita et al. showed that the expression of lipocalin-2 is stimulated by amyloid-beta (Aβ) 1-42 in Alzheimer’s disease (AD) [36].